Chemed Corp. (NYSE: CHE) reported Q4 EPS of $1.45, $0.02 better than the analyst estimate of $1.43. Revenue for the quarter came in at $350 million versus the consensus estimate of $353.47 million.

Chemed Corp. sees FY2012 EPS of $5.35-$5.55, versus the consensus of $5.27.

For earnings history and earnings-related data on Chemed Corp. (CHE) click here.

Earnings Guidance Hot Guidance